MILES HAMBERG: Open Payments
NPI 1275266629 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,917 in 67 payments from 20 companies in 2025. Trend: 2023 $1,140 · 2024 $1,439 · 2025 $2,917
Food & beverage: $1,778Travel & lodging: $1,139
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $1,421 |
| Sumitomo Pharma America, Inc. | 12 | $319 |
| ConvaTec Inc. | 13 | $245 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $163 |
| Janssen Biotech, Inc. | 4 | $108 |
| ABBVIE INC. | 4 | $89 |
| PFIZER INC. | 4 | $85 |
| Astellas Pharma US Inc | 2 | $61 |
| Ferring Pharmaceuticals Inc. | 3 | $59 |
| UROGEN PHARMA, INC. | 1 | $44 |
Products named: Axonics, ORGOVYX, GENTLECATH, Nubeqa, XTANDI, ERLEADA, GEMTESA, BOTOX.
Industry payments across CO — which companies pay providers there.
